泰宗生物科技股份有限公司
泰宗生物科技股份有限公司為全方位生技醫藥商，核心業務包括肝病新藥研發、骨科關節保養醫材、血球分離系統及高品質學名藥代理銷售。產品供應全台各大醫院與診所。公司成立於 1998 年，總部位於台灣新北。
該股 RSI(6) 為 16.7，處於超賣區間，短線跌深可能有反彈機會。股價跌破5日、20日、60日、120日均線。KD 指標偏低（K=17.8），有反彈空間；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-11 | +106 | 0 | +1 | +107 |
| 08-10 | +21 | 0 | 0 | +21 |
| 08-07 | +1 | 0 | 0 | +1 |
| 08-06 | +4 | 0 | -1 | +3 |
| 08-05 | -9 | 0 | -1 | -10 |
| 08-04 | -12 | 0 | 0 | -12 |
| 08-03 | -42 | 0 | -3 | -45 |
| 07-31 | -236 | 0 | +1 | -235 |
| 07-30 | -228 | 0 | +1 | -227 |
| 07-29 | +8 | 0 | 0 | +8 |
| 07-28 | +10 | 0 | 0 | +10 |
| 07-27 | +1 | 0 | 0 | +1 |
| 07-24 | -1 | 0 | -2 | -3 |
| 07-22 | -7 | 0 | +1 | -6 |
| 07-21 | +4 | 0 | +2 | +6 |
| 07-20 | -18 | 0 | -1 | -19 |
| 07-17 | -21 | 0 | +1 | -20 |
| 07-16 | -26 | 0 | +1 | -25 |
| 07-15 | -16 | 0 | -1 | -17 |
| 07-14 | +64 | 0 | 0 | +64 |
| 07-13 | -31 | 0 | +1 | -30 |
| 07-09 | -44 | 0 | -1 | -45 |
| 07-08 | +51 | 0 | -17 | +34 |
| 07-07 | +594 | 0 | +3 | +596 |
| 07-06 | -2 | 0 | +8 | +6 |
| 07-03 | -6 | 0 | +5 | -2 |
| 07-02 | -51 | 0 | 0 | -51 |
| 07-01 | -28 | 0 | -10 | -38 |
| 06-30 | +13 | 0 | -17 | -4 |
| 06-29 | +48 | 0 | -14 | +34 |
| 06-26 | +10 | 0 | -8 | +2 |
| 06-25 | -46 | 0 | 0 | -46 |
| 06-24 | +98 | 0 | -12 | +86 |
| 06-22 | +24 | 0 | -50 | -26 |
| 06-18 | -76 | 0 | +5 | -71 |
| 06-17 | +18 | 0 | 0 | +18 |
| 06-16 | +18 | 0 | 0 | +18 |
| 06-15 | -9 | 0 | 0 | -9 |
| 06-12 | +65 | 0 | 0 | +65 |
| 06-10 | +1 | 0 | 0 | +1 |
| 06-09 | -7 | 0 | -1 | -8 |
| 06-08 | -47 | 0 | 0 | -47 |
| 06-04 | +41 | 0 | 0 | +41 |
| 06-03 | -64 | 0 | 0 | -64 |
| 06-02 | +40 | 0 | 0 | +40 |
| 06-01 | +51 | 0 | +7 | +58 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/06 | 6478 萬 | +13.3% | +4.0% |
| 2026/05 | 5716 萬 | -3.3% | -17.2% |
| 2026/04 | 5914 萬 | -4.3% | - |
| 2026/03 | 6178 萬 | +34.8% | - |
| 2026/02 | 4585 萬 | -29.8% | - |
| 2026/01 | 6526 萬 | - | - |